78 related articles for article (PubMed ID: 22215016)
1. Foamy virus vector-mediated gene correction of a mouse model of Wiskott-Aldrich syndrome.
Uchiyama T; Adriani M; Jagadeesh GJ; Paine A; Candotti F
Mol Ther; 2012 Jun; 20(6):1270-9. PubMed ID: 22215016
[TBL] [Abstract][Full Text] [Related]
2. Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome.
Rai R; Romito M; Rivers E; Turchiano G; Blattner G; Vetharoy W; Ladon D; Andrieux G; Zhang F; Zinicola M; Leon-Rico D; Santilli G; Thrasher AJ; Cavazza A
Nat Commun; 2020 Aug; 11(1):4034. PubMed ID: 32788576
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.
Aiuti A; Biasco L; Scaramuzza S; Ferrua F; Cicalese MP; Baricordi C; Dionisio F; Calabria A; Giannelli S; Castiello MC; Bosticardo M; Evangelio C; Assanelli A; Casiraghi M; Di Nunzio S; Callegaro L; Benati C; Rizzardi P; Pellin D; Di Serio C; Schmidt M; Von Kalle C; Gardner J; Mehta N; Neduva V; Dow DJ; Galy A; Miniero R; Finocchi A; Metin A; Banerjee PP; Orange JS; Galimberti S; Valsecchi MG; Biffi A; Montini E; Villa A; Ciceri F; Roncarolo MG; Naldini L
Science; 2013 Aug; 341(6148):1233151. PubMed ID: 23845947
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
Labrosse R; Chu JI; Armant MA; Everett JK; Pellin D; Kareddy N; Frelinger AL; Henderson LA; O'Connell AE; Biswas A; Coenen-van der Spek J; Miggelbrink A; Fiorini C; Adhikari H; Berry CC; Cantu VA; Fong J; Jaroslavsky J; Karadeniz DF; Li QZ; Reddy S; Roche AM; Zhu C; Whangbo JS; Dansereau C; Mackinnon B; Morris E; Koo SM; London WB; Baris S; Ozen A; Karakoc-Aydiner E; Despotovic JM; Forbes Satter LR; Saitoh A; Aizawa Y; King A; Nguyen MAT; Vu VDU; Snapper SB; Galy A; Notarangelo LD; Bushman FD; Williams DA; Pai SY
Blood; 2023 Oct; 142(15):1281-1296. PubMed ID: 37478401
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for Wiskott-Aldrich syndrome: History, new vectors, future directions.
Ferrua F; Marangoni F; Aiuti A; Roncarolo MG
J Allergy Clin Immunol; 2020 Aug; 146(2):262-265. PubMed ID: 32623069
[No Abstract] [Full Text] [Related]
6. Foamy virus vectors for gene transfer.
Trobridge GD
Expert Opin Biol Ther; 2009 Nov; 9(11):1427-36. PubMed ID: 19743892
[TBL] [Abstract][Full Text] [Related]
7. A single-cell atlas of immunocytes in the spleen of a mouse model of Wiskott-Aldrich syndrome.
Liang F; Peng C; Luo X; Wang L; Huang Y; Yin L; Yue L; Yang J; Zhao X
Cell Immunol; 2023; 393-394():104783. PubMed ID: 37944382
[TBL] [Abstract][Full Text] [Related]
8. Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo.
Kiem HP; Wu RA; Sun G; von Laer D; Rossi JJ; Trobridge GD
Gene Ther; 2010 Jan; 17(1):37-49. PubMed ID: 19741733
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1.
Smith RH; Bloomer H; Fink D; Keyvanfar K; Nasimuzzaman M; Sancheznieto F; Dutta R; Guenther Bui K; Alvarado LJ; Bauer TR; Hickstein DD; Russell DW; Malik P; van der Loo JCM; Highfill SL; Kuhns DB; Pirooznia M; Larochelle A
Hum Gene Ther; 2022 Dec; 33(23-24):1293-1304. PubMed ID: 36094106
[No Abstract] [Full Text] [Related]
10. Establishment of a Dual-Vector System for Gene Delivery Utilizing Prototype Foamy Virus.
Cho SY; Lee YJ; Jung SM; Son YM; Shin CG; Kim ET; Kim KD
J Microbiol Biotechnol; 2024 Apr; 34(4):804-811. PubMed ID: 38379304
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic Stem Cell Therapy for Wiskott-Aldrich Syndrome: Improved Outcome and Quality of Life.
Mallhi KK; Petrovic A; Ochs HD
J Blood Med; 2021; 12():435-447. PubMed ID: 34149291
[TBL] [Abstract][Full Text] [Related]
12. Gene editing-based targeted integration for correction of Wiskott-Aldrich syndrome.
Pille M; Avila JM; Park SH; Le CQ; Xue H; Haerynck F; Saxena L; Lee C; Shpall EJ; Bao G; Vandekerckhove B; Davis BR
Mol Ther Methods Clin Dev; 2024 Mar; 32(1):101208. PubMed ID: 38414825
[TBL] [Abstract][Full Text] [Related]
13. Feline foamy virus-based vectors: advantages of an authentic animal model.
Liu W; Lei J; Liu Y; Lukic DS; Räthe AM; Bao Q; Kehl T; Bleiholder A; Hechler T; Löchelt M
Viruses; 2013 Jul; 5(7):1702-18. PubMed ID: 23857307
[TBL] [Abstract][Full Text] [Related]
14. Dupilumab for Post-Hematopoietic Cell Transplantation Dermatitis in Wiskott-Aldrich Syndrome.
Adir D; Freund T; Dotan A; Mashiah J; Hagin D
J Clin Immunol; 2023 Oct; 43(7):1526-1528. PubMed ID: 37247109
[No Abstract] [Full Text] [Related]
15. FV Vectors as Alternative Gene Vehicles for Gene Transfer in HSCs.
Simantirakis E; Tsironis I; Vassilopoulos G
Viruses; 2020 Mar; 12(3):. PubMed ID: 32204324
[TBL] [Abstract][Full Text] [Related]
16. Rare Genetic Blood Disease Modeling in Zebrafish.
Rissone A; Burgess SM
Front Genet; 2018; 9():348. PubMed ID: 30233640
[TBL] [Abstract][Full Text] [Related]
17. Foamy Virus Vectors Transduce Visceral Organs and Hippocampal Structures following In Vivo Delivery to Neonatal Mice.
Counsell JR; Karda R; Diaz JA; Carey L; Wiktorowicz T; Buckley SMK; Ameri S; Ng J; Baruteau J; Almeida F; de Silva R; Simone R; Lugarà E; Lignani G; Lindemann D; Rethwilm A; Rahim AA; Waddington SN; Howe SJ
Mol Ther Nucleic Acids; 2018 Sep; 12():626-634. PubMed ID: 30081233
[TBL] [Abstract][Full Text] [Related]
18. Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression.
Han F; Miyagawa Y; Verlengia G; Ingusci S; Soukupova M; Simonato M; Glorioso JC; Cohen JB
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950408
[TBL] [Abstract][Full Text] [Related]
19. Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.
Candotti F
J Clin Immunol; 2018 Jan; 38(1):13-27. PubMed ID: 29086100
[TBL] [Abstract][Full Text] [Related]
20. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
